Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Therapeutic Delivery
|
April 6, 2013
Implications of increased nanoparticle absorption by infant lungs: future prospects
Lucila Garcia-Contreras, Mariam Ibrahim
Therapeutic Delivery
|
August 8, 2013
Mechanisms of absorption and elimination of drugs administered by inhalation
Mariam Ibrahim, Lucila Garcia-Contreras
Critical Reviews in Therapeutic Drug Carrier Systems
|
February 13, 2004
Aerosol treatment of cystic fibrosis
Lucila Garcia-Contreras, Anthony J Hickey
Current Pharmaceutical Design
|
August 21, 2015
Inhaled Formulation Design for the Treatment of Lung Infections
Lucila Garcia-Contreras, Khushwant S Yadav
Advanced Drug Delivery Reviews
|
November 30, 2002
Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy
Lucila Garcia-Contreras, Anthony J Hickey
Frontiers in Cellular and Infection Microbiology
|
September 14, 2012
Pharmaceutical aerosols for the treatment and prevention of tuberculosis
Shumaila N M Hanif, Lucila Garcia-Contreras
Pharmaceutics
|
June 28, 2023
Designing Aerosol Therapies Based on the Integrated Evaluation of In Vitro, In Vivo, and In Silico Data
Margaret Bourlon, Yu Feng, Lucila Garcia-Contreras
Medical Devices (Auckland, N.Z.)
|
February 25, 2015
Inhalation drug delivery devices: technology update
Mariam Ibrahim, Rahul Verma, Lucila Garcia-Contreras
Advanced Drug Delivery Reviews
|
September 29, 2007
In vivo animal models for drug delivery across the lung mucosal barrier
Sally-Ann Cryan, Neeraj Sivadas, Lucila Garcia-Contreras
Molecular Pharmaceutics
|
December 9, 2017
SHetA2 Dry Powder Aerosols for Tuberculosis: Formulation, Design, and Optimization Using Quality by Design
Mariam Ibrahim, Manolya Kukut Hatipoglu, Lucila Garcia-Contreras
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Therapeutic Delivery
|
April 6, 2013
Implications of increased nanoparticle absorption by infant lungs: future prospects
Lucila Garcia-Contreras, Mariam Ibrahim
Therapeutic Delivery
|
August 8, 2013
Mechanisms of absorption and elimination of drugs administered by inhalation
Mariam Ibrahim, Lucila Garcia-Contreras
Critical Reviews in Therapeutic Drug Carrier Systems
|
February 13, 2004
Aerosol treatment of cystic fibrosis
Lucila Garcia-Contreras, Anthony J Hickey
Current Pharmaceutical Design
|
August 21, 2015
Inhaled Formulation Design for the Treatment of Lung Infections
Lucila Garcia-Contreras, Khushwant S Yadav
Advanced Drug Delivery Reviews
|
November 30, 2002
Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy
Lucila Garcia-Contreras, Anthony J Hickey
Frontiers in Cellular and Infection Microbiology
|
September 14, 2012
Pharmaceutical aerosols for the treatment and prevention of tuberculosis
Shumaila N M Hanif, Lucila Garcia-Contreras
Pharmaceutics
|
June 28, 2023
Designing Aerosol Therapies Based on the Integrated Evaluation of In Vitro, In Vivo, and In Silico Data
Margaret Bourlon, Yu Feng, Lucila Garcia-Contreras
Medical Devices (Auckland, N.Z.)
|
February 25, 2015
Inhalation drug delivery devices: technology update
Mariam Ibrahim, Rahul Verma, Lucila Garcia-Contreras
Advanced Drug Delivery Reviews
|
September 29, 2007
In vivo animal models for drug delivery across the lung mucosal barrier
Sally-Ann Cryan, Neeraj Sivadas, Lucila Garcia-Contreras
Molecular Pharmaceutics
|
December 9, 2017
SHetA2 Dry Powder Aerosols for Tuberculosis: Formulation, Design, and Optimization Using Quality by Design
Mariam Ibrahim, Manolya Kukut Hatipoglu, Lucila Garcia-Contreras
Page
of 4